GB
GB · GB · GB-APID-3638211000001100
Neo-Naclex-K modified-release tablets
ATC C03AA
Last synced from NHS dm+d (United Kingdom) on
Identification
ManufacturerMercury Pharma Group Ltd
CountryGB (GB)
ATC codeC03AA
Dispensing—
ReimbursedNo
SourceNHS dm+d (United Kingdom)
Last synced6/5/2026
Packs · 1
- gtin5021691910008
Annotations
No annotations yet.
Raw payload (JSON)
{
"apid": "3638211000001100",
"desc": "Neo-Naclex-K modified-release tablets (Mercury Pharma Group Ltd)",
"form": "Modified-release tablet",
"vpid": "35910111000001106",
"source": "dmd",
"vtm_id": "774766007",
"strength": "630 mg",
"substance": "Bendroflumethiazide + Potassium",
"ingredient": "Potassium chloride",
"supplier_code": "151601000001102"
}Related drugs
Other records sharing ATC code C03AA.
- 🇺🇸AvalideSanofi-Aventis U.S. LLC
- 🇺🇸AvalideSanofi-Aventis U.S. LLC
- 🇺🇸Benicar HCTCosette Pharmaceuticals, Inc.
- 🇺🇸Benicar HCTCosette Pharmaceuticals, Inc.
- 🇺🇸Benicar HCTCosette Pharmaceuticals, Inc.
- 🇺🇸Benicar HCTCosette Pharmaceuticals, Inc.
- 🇺🇸Benicar HCTCosette Pharmaceuticals, Inc.
- 🇺🇸Benicar HCTCosette Pharmaceuticals, Inc.
Access this data programmatically
Query Neo-Naclex-K modified-release tablets and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.